NAVAo — Navamedic ASA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- NOK590.03m
- NOK703.49m
- NOK512.00m
Annual cashflow statement for Navamedic ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.5 | -16.6 | 2.36 | 42.5 | 10.8 |
| Depreciation | |||||
| Non-Cash Items | -7.73 | 5.91 | 6.32 | -0.696 | 12.8 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 32.3 | 3.85 | -16.7 | -31.1 | -33.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12.7 | -3.18 | -1.3 | 17.9 | 2.18 |
| Capital Expenditures | -0.721 | -4.99 | -0.728 | -2.25 | -2.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.13 | -18.1 | 0.001 | -23.2 | -102 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.85 | -23.1 | -0.727 | -25.4 | -105 |
| Financing Cash Flow Items | -0.578 | -1.84 | -1.47 | -3.27 | -7.23 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -10.9 | 51.8 | 15.9 | 10.1 | 83.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.393 | 28.1 | 13 | 2.68 | -17.3 |